Tumor-specific CD4+ T cells have a major 'post-licensing' role in CTL mediated anti-tumor immunity

A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins, B. W.S. Robinson, B. Scott

Research output: Contribution to journalArticlepeer-review

277 Scopus citations

Fingerprint

Dive into the research topics of 'Tumor-specific CD4<sup>+</sup> T cells have a major 'post-licensing' role in CTL mediated anti-tumor immunity'. Together they form a unique fingerprint.

Medicine & Life Sciences